Lindbrook Capital’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
NAMA
Lindbrook Capital's TWST Position: Q1 2025 in Review
Lindbrook Capital increased its Twist Bioscience (TWST) stake by 33% in Q1 2025, buying an estimated $721 and bringing the position to 65 shares worth $2.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2210.
Lindbrook Capital first reported a position in TWST in Q2 2020 and has held it in 20 quarters since. The position peaked at $15K in Q1 2021. 263 funds tracked by Wall St. Rank hold TWST as of Q1 2025.
- Lindbrook Capital held 65 shares of Twist Bioscience worth $2.55K as of Q1 2025.
- Lindbrook Capital bought 16 Twist Bioscience shares in Q1 2025, an estimated $721.
- Twist Bioscience made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2210 holding.
- Lindbrook Capital first reported a position in Twist Bioscience in Q2 2020 and has held it in 20 quarters since.
- Lindbrook Capital's Twist Bioscience position peaked at $15K in Q1 2021.
- 263 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.